First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors
Clinical trial NCT04746612 · TERMINATED
Trial details
- NCT number
- NCT04746612
- Sponsor
- Haihe Biopharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-08
- Primary completion
- 2023-03-24
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.